Gregory Vladimir

Gregory Vladimir

Company: Exscientia

Job title: Vice President, Translational Research


Patient-First Drug Discovery Using Primary Patient Tissues and AI 1:40 pm

The use of primary tissues from cancer patients in translational research provides disease-relevant model systems High-content microscopy, transcriptomics, and AI are powerful tools to enable single-cell interrogation of drug and target function within diseased tissue, harnessing potential inter-patient response heterogeneity for preclinical biomarker prediction. Our methodology for assessing functional drug response has been clinically validated…Read more

day: Track A - Day 2 am

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.